STX2 and hemolytic-uremic syndrome: The 2022 European surveillance report indicated that 44.8% of STEC strains isolated from severe human cases, including HUS and bloody diarrhea, were positive for both stx2 and eae, further emphasizing the pathogenic potential of strains with these virulence traits in clinical settings [3,4].